U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  1. Vaccines

STN: BLA 125772
Proper Name: etranacogene dezaparvovec-drlb
Tradename:  HEMGENIX
Manufacturer: CSL Behring LLC

  • HEMGENIX is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who:
    •Currently use Factor IX prophylaxis therapy, or
    •Have current or historical life-threatening hemorrhage, or
    •Have repeated, serious spontaneous bleeding episodes.

Product Information

Supporting Documents


Back to Top